INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-955812666 patient recruitment]( "How To Reduce Screen Fail Rates")
How To Reduce Screen Fail RatesExplore the causes of high screen fail rates, their impact on patient recruitment for clinical trials, and how they disproportionately impact underrepresented demographics.
-
![exam, test, analysis, innovation, development-GettyImages-2149039471]( "Why Bioanalysis Needs To Break Free From Manual Bottlenecks")
Why Bioanalysis Needs To Break Free From Manual BottlenecksBioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
![Cancer patient oncology unit-GettyImages-1169640471]( "Accelerating Enrollment And Upholding Quality In Complex Oncology Trials")
Accelerating Enrollment And Upholding Quality In Complex Oncology TrialsReal-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
-
![Meeting Patients where they are]( "Meeting Patients Where They Are With Clinical Trials")
Meeting Patients Where They Are With Clinical TrialsDiscover how to bridge gaps in patient diversity by fostering community trust and implementing inclusive research strategies.
-
How To Accelerate Early-Phase Oncology Trial5/12/2026
Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
Navigating Late-Phase Clinical Trial Enrollment: Strategies To Stay On Schedule1/22/2026
Late-phase trial delays cause massive revenue loss. This piece outlines AI pre-screening, direct-to-patient scaling, and retention tactics to hit study goals on time and ensure market readiness.
-
Evidence Of An Industry's Readiness To Collaborate11/13/2024
The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.
-
Accelerate Drug Development With Master Protocols5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
Community Connections: Leveraging Localized Patient Access In Clinical Trials10/28/2025
This roundtable brought together several experts to discuss how expanding community-based research can transform clinical trial recruitment and representation.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1293772969 lab testing]( "How ClinicReady Delivers Foundations For Success")
ClinicReady is the surrogate for outsourced drug development team for preclinical biotechs.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "De-Risk Randomization With The Endpoint Biostatistical Approach")
With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
-
![GettyImages-1819626829 patient recruitment]( "Precision Recruitment Is the Name of the Game")
Leverage an exhaustive view of patients, diseases, and providers to precisely identify protocol-specific populations within a sponsor’s site network.
-
![GettyImages-10977380780 science-liquid-beaker]( "The Benefits From NetSuite SuiteSuccess Implementation")
Explore an innovative, automated approach that streamlines processes, strengthens financial controls, and accelerates readiness for Equity Events/Sox Controls, and much more.
-
![GettyImages-2199680273-lab-computer-scientist-in-lab-coat]( "Adherence Monitoring Solutions: Choose The Right Level Of Support")
Help your study team curb trial costs and delays by monitoring adherence in near real time. These tools automate reporting and issue alerts to maximize data capture and regulatory readiness.
